Tags

Type your tag names separated by a space and hit enter

Evaluation of the growth inhibitory activities of Triphala against common bacterial isolates from HIV infected patients.
Phytother Res. 2007 May; 21(5):476-80.PR

Abstract

The isolation of microbial agents less susceptible to regular antibiotics and the rising trend in the recovery rates of resistant bacteria highlights the need for newer alternative principles. Triphala has been used in traditional medicine practice against certain diseases such as jaundice, fever, cough, eye diseases etc. In the present study phytochemical (phenolic, flavonoid and carotenoid) and antibacterial activities of aqueous and ethanol extracts of Triphala and its individual components (Terminalia chebula, Terminalia belerica and Emblica officinalis) were tested against certain bacterial isolates (Pseudomonas aeruginosa, Klebsiella pneumoniae, Shigella sonnei, S. flexneri, Staphylococcus aureus, Vibrio cholerae, Salmonella paratyphi-B, Escherichia coli, Enterococcus faecalis, Salmonella typhi) obtained from HIV infected patients using Kirby-Bauer's disk diffusion and minimum inhibitory concentration (MIC) methods. T. chebula was found to possess high phytochemical content followed by T. belerica and E. officinalis in both aqueous and ethanol extracts. Further, most of the bacterial isolates were inhibited by the ethanol and aqueous extracts of T. chebula followed by T. belerica and E. officinalis by both disk diffusion and MIC methods. The present study revealed that both individual and combined aqueous and ethanol extracts of Triphala have antibacterial activity against the bacterial isolates tested.

Authors+Show Affiliations

Department of Physiology, Faculty of Medicine, Dr. ALM PG Institute of Basic Medical Sciences, University of Madras, Taramani Campus, Chennai, Tamilnadu, India 600 113.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

17273983

Citation

Srikumar, R, et al. "Evaluation of the Growth Inhibitory Activities of Triphala Against Common Bacterial Isolates From HIV Infected Patients." Phytotherapy Research : PTR, vol. 21, no. 5, 2007, pp. 476-80.
Srikumar R, Parthasarathy NJ, Shankar EM, et al. Evaluation of the growth inhibitory activities of Triphala against common bacterial isolates from HIV infected patients. Phytother Res. 2007;21(5):476-80.
Srikumar, R., Parthasarathy, N. J., Shankar, E. M., Manikandan, S., Vijayakumar, R., Thangaraj, R., Vijayananth, K., Sheeladevi, R., & Rao, U. A. (2007). Evaluation of the growth inhibitory activities of Triphala against common bacterial isolates from HIV infected patients. Phytotherapy Research : PTR, 21(5), 476-80.
Srikumar R, et al. Evaluation of the Growth Inhibitory Activities of Triphala Against Common Bacterial Isolates From HIV Infected Patients. Phytother Res. 2007;21(5):476-80. PubMed PMID: 17273983.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Evaluation of the growth inhibitory activities of Triphala against common bacterial isolates from HIV infected patients. AU - Srikumar,R, AU - Parthasarathy,N Jeya, AU - Shankar,E M, AU - Manikandan,S, AU - Vijayakumar,R, AU - Thangaraj,R, AU - Vijayananth,K, AU - Sheeladevi,R, AU - Rao,Usha Anand, PY - 2007/2/3/pubmed PY - 2007/7/10/medline PY - 2007/2/3/entrez SP - 476 EP - 80 JF - Phytotherapy research : PTR JO - Phytother Res VL - 21 IS - 5 N2 - The isolation of microbial agents less susceptible to regular antibiotics and the rising trend in the recovery rates of resistant bacteria highlights the need for newer alternative principles. Triphala has been used in traditional medicine practice against certain diseases such as jaundice, fever, cough, eye diseases etc. In the present study phytochemical (phenolic, flavonoid and carotenoid) and antibacterial activities of aqueous and ethanol extracts of Triphala and its individual components (Terminalia chebula, Terminalia belerica and Emblica officinalis) were tested against certain bacterial isolates (Pseudomonas aeruginosa, Klebsiella pneumoniae, Shigella sonnei, S. flexneri, Staphylococcus aureus, Vibrio cholerae, Salmonella paratyphi-B, Escherichia coli, Enterococcus faecalis, Salmonella typhi) obtained from HIV infected patients using Kirby-Bauer's disk diffusion and minimum inhibitory concentration (MIC) methods. T. chebula was found to possess high phytochemical content followed by T. belerica and E. officinalis in both aqueous and ethanol extracts. Further, most of the bacterial isolates were inhibited by the ethanol and aqueous extracts of T. chebula followed by T. belerica and E. officinalis by both disk diffusion and MIC methods. The present study revealed that both individual and combined aqueous and ethanol extracts of Triphala have antibacterial activity against the bacterial isolates tested. SN - 0951-418X UR - https://www.unboundmedicine.com/medline/citation/17273983/Evaluation_of_the_growth_inhibitory_activities_of_Triphala_against_common_bacterial_isolates_from_HIV_infected_patients_ L2 - https://doi.org/10.1002/ptr.2105 DB - PRIME DP - Unbound Medicine ER -